This titration strategy served several purposes: Reduced the severity of gastrointestinal side effects such as nausea, vomiting, and diarrhea Allowed clinicians to identify dose thresholds for tolerability versus efficacy Ensured progressive exposure to triple agonist activity without overwhelming the bodys hormonal systems Monitoring and Adjustments During escalation, patients were monitored for: Glucose control and insulin sensitivity Cardiovascular markers such as blood pressure and lipid profiles Liver enzymes and kidney function to assess safety at higher doses Adverse event reporting, especially GI events, which tend to peak during dose escalation This monitoring informed adjustments some participants remained at moderate doses if they were unable to tolerate higher weekly injections
Weight loss begins in earnest
After reconstitution, both compounds should be refrigerated and used within 28 to 30 days
There is a ceiling, and you cannot break through it by taking more
Because the cause is delayed gastric emptying, other GLP-1 (and dual-agonist) medications such as Wegovy, tirzepatide, and similar drugs can produce the same effect
Talk with your clinician about whether one of these might be worth trying: Ashwagandha: An adaptogen that regulates the bodys stress response system